Cargando…
Metformin Attenuates Cardiac Hypertrophy Via the HIF-1α/PPAR-γ Signaling Pathway in High-Fat Diet Rats
Coronary artery disease (CAD) and cardiac hypertrophy (CH) are two main causes of ischemic heart disease. Acute CAD may lead to left ventricular hypertrophy (LVH). Long-term and sustained CH is harmful and can gradually develop into cardiac insufficiency and heart failure. It is known that metformin...
Autores principales: | Liu, Yuansheng, Zhang, Qian, Yang, Lei, Tian, Wencong, Yang, Yinan, Xie, Yuhang, Li, Jing, Yang, Liang, Gao, Yang, Xu, Yang, Liu, Jie, Wang, Yachen, Yan, Jie, Li, Guoxun, Shen, Yanna, Qi, Zhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271627/ https://www.ncbi.nlm.nih.gov/pubmed/35833024 http://dx.doi.org/10.3389/fphar.2022.919202 |
Ejemplares similares
-
Metformin potentiates anti-tumor effect of resveratrol on pancreatic cancer by down-regulation of VEGF-B signaling pathway
por: Zhu, Mengmeng, et al.
Publicado: (2016) -
Asarinin attenuates bleomycin-induced pulmonary fibrosis by activating PPARγ
por: Zeng, Qian, et al.
Publicado: (2023) -
PPARγ Transcription Deficiency Exacerbates High-Fat Diet-Induced Adipocyte Hypertrophy and Insulin Resistance in Mice
por: Guo, Fusheng, et al.
Publicado: (2020) -
Metformin attenuates myocardial ischemia-reperfusion injury via up-regulation of antioxidant enzymes
por: Wang, Xiaoling, et al.
Publicado: (2017) -
Metformin promotes osteogenic differentiation and prevents hyperglycaemia-induced osteoporosis by suppressing PPARγ expression: Metformin prevents osteoporosis by suppressing PPARγ
por: Zheng, Lifeng, et al.
Publicado: (2023)